- 抑制劑
- 研究領(lǐng)域
- PI3K/Akt/mTOR信號(hào)通路
- 表觀遺傳
- 甲基化
- 免疫&炎癥
- 酪氨酸蛋白激酶
- 血管生成
- 凋亡
- 自噬
- 內(nèi)質(zhì)網(wǎng)應(yīng)激&UPR響應(yīng)
- JAK/STAT信號(hào)通路
- MAPK信號(hào)通路
- 細(xì)胞骨架
- 細(xì)胞周期
- TGF-beta/Smad信號(hào)通路
- DNA損傷/DNA修復(fù)
- 化合物庫(kù)
- 抗體
- 生物試劑
- qPCR
- 2x SYBR Green qPCR Master Mix
- 2x SYBR Green qPCR Master Mix(Low ROX)
- 2x SYBR Green qPCR Master Mix(High ROX)
- 蛋白實(shí)驗(yàn)
- Protein A/G免疫沉淀磁珠
- Anti-DYKDDDDK Tag免疫磁珠
- Anti-DYKDDDDK Tag親和凝膠
- Anti-Myc免疫磁珠
- Anti-HA免疫磁珠
- 磁力架
- Poly DYKDDDDK Tag多肽
- 蛋白酶抑制劑Cocktail
- 蛋白酶抑制劑Cocktail(DMSO儲(chǔ)液)
- 磷酸酶抑制劑Cocktail
- 細(xì)胞實(shí)驗(yàn)
- Cell Counting Kit-8 (CCK-8)
- 動(dòng)物實(shí)驗(yàn)
- 鼠尾直接PCR試劑盒(快速基因型鑒定)
- 小鼠CD3+ T細(xì)胞分選試劑盒
- 小鼠CD4+ T細(xì)胞分選試劑盒
- 小鼠CD8+ T細(xì)胞分選試劑盒
- 新產(chǎn)品
- 聯(lián)系我們
Capsazepine
中文名稱：辣椒平
Capsazepine是capsaicin的拮抗劑，是TRPV1的拮抗劑。細(xì)胞實(shí)驗(yàn)請(qǐng)選擇01批次。
Capsazepine Chemical Structure
CAS: 138977-28-3
產(chǎn)品質(zhì)控
批次：
純度：
99.66%
99.66
Capsazepine相關(guān)產(chǎn)品
| 相關(guān)靶點(diǎn) | TRPV TRPA TRPC TRPM TRPML | 點(diǎn)擊展開 |
|---|---|---|
| 相關(guān)產(chǎn)品 | SKF96365 AMG-517 HC-030031 2-APB (2-Aminoethyl Diphenylborinate) GSK2193874 GSK1016790A SB705498 Caffeic Acid HC-067047 Cinnamaldehyde RN-1734 Cardamonin ML204 SB366791 (-)-Menthol | 點(diǎn)擊展開 |
| 相關(guān)化合物庫(kù) | FDA藥物庫(kù) 天然產(chǎn)物庫(kù) 離子通道配體庫(kù) 外泌體分泌相關(guān)化合物庫(kù) 鈣通道阻滯劑庫(kù) | 點(diǎn)擊展開 |
細(xì)胞實(shí)驗(yàn)數(shù)據(jù)示例
| 細(xì)胞系 | 實(shí)驗(yàn)類型 | 給藥濃度 | 孵育時(shí)間 | 活性描述 | 文獻(xiàn)信息 |
|---|---|---|---|---|---|
| HEK293T | Function assay | 100 uM | Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of proton-induced intracellular Ca2+ influx at 100 uM by fluorescence-based assay | 24484240 | |
| HEK T-REx cells | Function assay | >50 uM | Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of icilin-induced intracellular Ca2+ influx at >50 uM by fluorescence-based assay | 24484240 | |
| HEK293T | Function assay | 10 uM | Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of proton-induced intracellular Ca2+ influx at 10 uM by fluorescence-based assay | 24484240 | |
| T-REx HEK cells | Function assay | 3 mins | Antagonist activity against human TRPV1 expressed in T-REx HEK cells assessed as inhibition of capsaicin-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to capsaicin stimulation by Fluo-4 AM dye based fluorescence assay, IC50=0.068μM | 25052206 | |
| T-REx HEK cells | Function assay | 3 mins | Antagonist activity against mouse TRPM8 expressed in T-REx HEK cells assessed as inhibition of cold-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to cold stimulation by Fluo-4 AM dye based fluorescence assay | 25052206 | |
| HeLa | Antiproliferative assay | 24 hrs | Antiproliferative activity against human HeLa cells after 24 hrs by cell titer 96 aqueous non-radioactive cell proliferation assay, IC50=30μM | 30528162 | |
| HEK293T | Function assay | Antagonist activity at human brain TRPV1 expressed in HEK293T cells assessed as inhibition of CAP-induced intracellular Ca2+ influx by fluorescence-based assay, IC50=0.15μM | 24484240 | ||
| HEK293 | Function assay | Antagonist activity at human TRPV1 expressed in tetracycline-stimulated HEK293 cells assessed as inhibition of capsaicin-induced intracellular calcium levels by fluorimetric assay, EC50=2.51189μM | 20381363 | ||
| CHO | Function assay | Displacement of [3H]RTX from rat TRPV1 receptor expressed in CHO cells, Ki=1.3μM | 18072720 | ||
| CHO | Function assay | Antagonist activity at rat TRPV1 receptor expressed in CHO cells assessed as calcium 45 uptake, Ki=0.52μM | 18072720 | ||
| CHO | Function assay | Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by [45Ca2+] uptake assay, IC50=0.887μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by aequorin based assay, IC50=0.32μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at rat TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by aequorin based assay, IC50=0.22μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of acid-induced receptor activation by [45Ca2+] uptake assay, IC50=0.069μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by [45Ca2+] uptake assay, IC50=0.053μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at human TRPV1 expressed in CHO cells assessed as blockade of capsaicin-induced receptor activation by aequorin based assay, IC50=0.039μM | 17489570 | ||
| CHO | Function assay | Antagonist activity at rat TRPV1 expressed in CHO cells assessed as inhibition of calcium uptake, Ki=0.52μM | 17035013 | ||
| CHO | Function assay | Displacement of [3H]RTX from rat TRPV1 expressed in CHO cells, Ki=1.3μM | 17035013 | ||
| human TRPV1 expressing cells | Function assay | Inhibition of calcium influx evoked by capsaicin in human TRPV1 expressing cells by fluorescence assay, IC50=0.334μM | 16420034 | ||
| CHO | Function assay | In vitro binding affinity for rat TRPV1 expressed in CHO cells using [3H]-RTX, Ki=1.3μM | 16005215 | ||
| CHO | Function assay | Antagonist activity for rat TRPV1 expressed in CHO cells, Ki=0.52μM | 16005215 | ||
| CHO | Function assay | In vitro inhibition of [3H]RTX binding to rat TRPV1 expressed in CHO cells, Ki=1.3μM | 15993063 | ||
| HEK293 | Function assay | Inhibition of 100 nM capsaicin effect on intracellular [Ca2+] concentration in HEK293 cells expressing human TRPV1, IC50=0.0562μM | 16000002 | ||
| CHO | Function assay | Antagonist activity towards rat TRPV1 expressed in CHO cells, Ki=0.52μM | 15993063 | ||
| CHO | Function assay | Inhibition of capsaicin-induced [Ca2+] uptake by Rat Vanilloid receptor 1 (VR1) expressing CHO cells, Ki=0.52μM | 12825950 | ||
| CHO | Function assay | Inhibition of capsaicin-induced calcium uptake by transient receptor potential vanilloid type 1 expressed in CHO cells, IC50=0.42μM | 15634002 | ||
| 點(diǎn)擊查看更多細(xì)胞系數(shù)據(jù) | |||||
生物活性
| 產(chǎn)品描述 | Capsazepine是capsaicin的拮抗劑，是TRPV1的拮抗劑。細(xì)胞實(shí)驗(yàn)請(qǐng)選擇01批次。 | ||||
|---|---|---|---|---|---|
| 靶點(diǎn) |
|
| 體外研究(In Vitro) | ||||
| 體外研究活性 | 94.2 µg/ml的Capsazepine(CPZ)對(duì)破骨細(xì)胞的生長(zhǎng)和增殖具有顯著的抑制[2]。 Capsazepine將NKA轉(zhuǎn)變?yōu)镹a-ATPase。CPZ抑制K+依賴性活性，但不影響Na+轉(zhuǎn)運(yùn)相關(guān)的Na-ATPase。在沒有K+的情況下，CPZ對(duì)Na-ATPase沒有作用。CPZ還能抑制對(duì)硝基磷酸酶活性，盡管親和力比較弱。CPZ顯著地減少穩(wěn)態(tài)EP水平?？傊?，CPZ阻滯NKA中Na+/K+循環(huán)，但保持Na+循環(huán)完整、減少泵的運(yùn)輸化學(xué)計(jì)量[3]。Capsazepine在骨髓-成骨細(xì)胞混合培養(yǎng)物及生成RNKL的破骨細(xì)胞中，劑量依賴性地抑制破骨細(xì)胞形成和骨吸收。Capsazepine還抑制RANKL誘導(dǎo)的IκB和ERK1/2的磷酸化，導(dǎo)致成熟破骨細(xì)胞的凋亡。在顱骨成骨細(xì)胞中還抑制堿性磷酸酶活性和骨結(jié)節(jié)形成[4]。 |
|||
|---|---|---|---|---|
| 細(xì)胞實(shí)驗(yàn) | 細(xì)胞系 | 小鼠巨噬細(xì)胞細(xì)胞株RAW 264.7 | ||
| 濃度 | 94.2 μg/ml | |||
| 孵育時(shí)間 | 72 h | |||
| 方法 | 將細(xì)胞鋪于細(xì)胞培養(yǎng)板中，并用不同濃度的化合物進(jìn)行處理，使得增殖72小時(shí)。72小時(shí)后，用10% formalin saline (50μl/well)固定細(xì)胞30分鐘。然后用crystal violet(0.05% w/v)對(duì)細(xì)胞進(jìn)行染色，染色時(shí)間為30分鐘。染色結(jié)束后，用蒸餾水沖洗幾遍，將未結(jié)合上的染料洗去，用Sorenson’s buffer進(jìn)行脫色。540 nm處測(cè)定其吸光值。 |
|||
| 體內(nèi)研究(In Vivo) | ||
| 體內(nèi)研究活性 | Capsazepine預(yù)處理可防止內(nèi)毒素血癥期間呼吸系統(tǒng)阻力的增加并減少組織阻尼的增加。 Capsazepine 還可通過減少脂多糖 (LPS) 引起的肺實(shí)質(zhì)塌陷面積來減輕肺損傷。 |
|
|---|---|---|
化學(xué)信息&溶解度
| 分子量 | 376.90 | 分子式 | C19H21ClN2O2S |
| CAS號(hào) | 138977-28-3 | SDF | Download Capsazepine SDF |
| Smiles | C1CC2=CC(=C(C=C2CN(C1)C(=S)NCCC3=CC=C(C=C3)Cl)O)O | ||
| 儲(chǔ)存條件(自收到貨起) | |||
|
體外溶解度 |
DMSO : Insoluble ( ；DMSO吸濕會(huì)降低化合物溶解度，請(qǐng)使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計(jì)算器 |
|
體內(nèi)溶解度 現(xiàn)配現(xiàn)用，請(qǐng)按從左到右的順序依次添加，澄清后再加入下一溶劑 |
動(dòng)物體內(nèi)配方計(jì)算器 | ||||
實(shí)驗(yàn)計(jì)算
摩爾濃度計(jì)算器
動(dòng)物體內(nèi)配方計(jì)算器（澄清溶液）
第一步：請(qǐng)輸入基本實(shí)驗(yàn)信息（考慮到實(shí)驗(yàn)過程中的損耗，建議多配一只動(dòng)物的藥量）
mg/kg
g
μL
只
第二步：請(qǐng)輸入動(dòng)物體內(nèi)配方組成（配方適用于不溶于水的藥物；不同批次藥物配方比例不同，請(qǐng)聯(lián)系Selleck為您提供正確的澄清溶液配方）
% DMSO
%
% Tween 80
% ddH2O
%DMSO
%
計(jì)算結(jié)果：
工作液濃度： mg/ml；
DMSO母液配制方法： mg 藥物溶于μL DMSO溶液（母液濃度mg/mL，注：如該濃度超過該批次藥物DMSO溶解度，請(qǐng)先聯(lián)系Selleck）；
體內(nèi)配方配制方法：取μL DMSO母液，加入μL PEG300，混勻澄清后加入μL Tween 80，混勻澄清后加入μL ddH2O，混勻澄清。
體內(nèi)配方配制方法：取μL DMSO母液，加入μL Corn oil，混勻澄清。
注意：1. 首先保證母液是澄清的；
2.一定要按照順序依次將溶劑加入，進(jìn)行下一步操作之前必須保證上一步操作得到的是澄清的溶液，可采用渦旋、超聲或水浴加熱等物理方法助溶。
技術(shù)支持
在訂購(gòu)、運(yùn)輸、儲(chǔ)存和使用我們的產(chǎn)品的任何階段，您遇到的任何問題，均可以通過撥打我們的熱線電話400-668-6834，或者技術(shù)支持郵箱tech@selleck.cn，直接聯(lián)系到我們。我們會(huì)在24小時(shí)內(nèi)盡快聯(lián)系您。
如果有其他問題，請(qǐng)給我們留言。
* 必填項(xiàng)
Tags: buy Capsazepine | Capsazepine supplier | purchase Capsazepine | Capsazepine cost | Capsazepine manufacturer | order Capsazepine | Capsazepine distributor
Copyright 2013 Selleck中國(guó). All Rights Reserved.
滬ICP備13045345號(hào)-1滬公網(wǎng)安備 31011502012800號(hào)
